Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthesis Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Bioanalytical Services
      • Large Molecule Services
      • Small Molecule Services
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
    • Integrated Projects
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Our Events
    • Market Activity
    • Press Events
  • Contact

Mini-Brains Created that Grow Blood Vessels

Home Press Events
NextPrevious

Mini-Brains Created that Grow Blood Vessels

By medicilon | Press Events | 7 February, 2017 |

    Scientists at Brown University have recently made a wondrous variety of mini-brains — 3-D cultures of neural cells that model basic properties of living brains — but a new finding could add to the field’s growing excitement in an entirely new “vein”: Brown University’s mini-brains now grow blood vessels, too.




    The networks of capillaries within the small balls of nervous system cells could enable new kinds of large-scale lab investigations into diseases, such as stroke or concussion, where the interaction between the brain and its circulatory system is paramount, said Diane Hoffman-Kim, Ph.D., senior author of the study (“A Three-Dimensional Neural Spheroid Model for Capillary-Like Network Formation”) that appears in the Journal of Neuroscience Methods.


    “This is exciting because real brains have vasculature,” said Dr. Hoffman-Kim, an associate professor of medical science and of engineering at Brown. “We rely on it. For our neurons to do their thing, they have to be close to some blood vessels. If we are going to study lab models of the brain, we would love for them to have vasculature, too.”


    Dr. Hoffman-Kim’s lab first described its mini-brain method in 2015. While the engineered tissues appeared relatively simple compared to some others, they were also relatively easy and inexpensive to make. But what had remained unnoticed at the time, even by the inventors, was that the little 8000-cell spheres cultured from mouse cells were capable of growing an elementary circulatory system.


    Only as members of the lab, including lead author and Brown Graduate School alumna Molly Boutin, Ph.D., continued to work with and study the mini-brains did they discover that after about day 3 of culture, about two-thirds of the mini-brains had grown networks of nonneural tissue, according to Dr. Hoffman-Kim. Closer inspection revealed that these tangles of spaghetti were self-assembled tubes made of the cells and proteins found in blood vessels.


    The new study features a variety of imaging experiments in which staining and fluorescence techniques reveal those different cell types and proteins within the mini-brain spheres. The study also documents their integration with the neural tissues. Cross-sections under a transmission electron microscope, meanwhile, show that the capillaries are indeed hollow tubes that could transport blood.


    Of course, there is no blood in a tiny mini-brain, Dr. Hoffman-Kim said. They exist in an agarose well plate, not in a living animal. But she’s currently working with a colleague at Brown to design a way to connect the mini-brains with a microfluidic apparatus that could produce an external source of circulation through a mini-brain. The capillary networks are not as dense as they would be in a real brain, she acknowledged, and the study also shows that they don’t last longer than about a week or two.


    Aware of both their constraints and their potential, Dr. Hoffman-Kim says her lab has already started experiments to take advantage of the presence of vasculature. Study second author Liana Kramer, a Brown senior, has begun looking at what happens to the vasculature and neural cells when mini-brains are deprived of oxygen or glucose. Later, that same test bed could be used to examine the difference that different drugs or other treatments make.


    Vasculature is particularly important not only because it delivers oxygen, glucose, and medicine to brain cells, but also because research shows that in strokes, Alzheimer’s disease, and brain injury, the brain sometimes attempts to redesign its vasculature to compensate for what’s happening to it. The mini-brains could allow researchers to observe such responses amid different lab-created conditions and treatments, notes Dr. Hoffman-Kim.


    “We can study a range of injury conditions, several drugs that are being tested, and several conditions, such as stroke and diabetes, together,” she explained.

No tags.

Related Post

  • Novel Research Model Offers Hope to ALS and MS Patients

    Scientists at the Karolinska Institute in Sweden have developed a new disease model for neurodegenerative disordersRead more

  • Human Brain Organoids Thrive in Mouse Brains

    Brain organoids, also known as mini-brains, are tiny clumps of brain cells grown from stem cellsRead more

  • Mitochondria Choked with Proteins Can Activate Gag Reflex

    When the cell tries to stuff too many proteins into its mitochondria, protein blockages and backupsRead more

  • Blood Pressure Drugs Work Best with Musical Accompaniment

    Listening to music heightens the beneficial effects of blood pressure–lowering drugs, according to the results ofRead more

  • Soluble Antibodies Play Immune Suppressive Role in Tumor Progression

    Scientists at the Wistar Institute have found that soluble antibodies promote tumor progression by inducing accumulationRead more

  • CRISPR Combines with Gene Delivery System to Create Brain Tumor Model

    In animal models, disease recapitulation is the guiding principle. Scientists spend considerable time and effort tryingRead more

  • “Sweet Tooth” Gene Variant Associated with Lower Body Fat

    A common variant of the gene for the liver hormone fibroblast growth factor 21 (FGF21) geneticallyRead more

  • Personalized Cancer Vaccine Shows Promise in Patients with Advanced Ovarian Cancer

    Ovarian cancer is a particularly hard-to-treat disease. It’s often diagnosed late, and even after surgery andRead more

NextPrevious

News

  • Our Events
  • Market Activity
  • Press Events

Top Posts

  • 14 October, 2016

    Preclinical Drug Development Process

  • 14 February, 2017

    IND Enabling Studies FDA

  • 7 February, 2017

    Target Identification and Validation in Drug Discovery

  • 15 February, 2017

    Drug Discovery and Development Services

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry Services
  • Biology Services
  • Bioanalytical Services
  • Drug Safety Evaluation
  • Formulation Development Services
  • Pharmacology Services
  • Pharmacokinetic Services
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.
Email: Marketing@medicilon.com.cn
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthesis Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Bioanalytical Services
      • Large Molecule Services
      • Small Molecule Services
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
    • Integrated Projects
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Our Events
    • Market Activity
    • Press Events
  • Contact
Medicilon Inc